With over 20 years of experience in healthcare management, Dr. Rocklage has exhibited strong leadership capabilities that will remain remarkable for years to come. Rocklage holds a P.H.D in Chemistry from Massacheutts Institute of Technology (MIS) and a Bachelor of Science in Chemistry earned from the University of California, Berkeley. His leadership has seen the endorsement of three U.S. New Drug Applications as well the entrance of a number of drug applicants into clinical trials.
Together with his wife Scott Patty, they assisted in the renovation of Lestor Wolfe Professor, nanotechnology lab as well as Moungi Bawendi’s nanochemistry in 2016. Scott Rocklage, the managing partner at 5AM Ventures, took up his role in 2004 where he rose from his rank as Venture Partner in just one year.
Before joining 5AM Ventures, he served as the Chairman and Chief Operating Officer of Cubist Pharmaceuticals as well the President of Nycomed Salutar.
The teams he has worked with have raised over $500 million in financing, a clear indication of his achievements so far. It is through his strategic leadership that the company he currently serves (5AM Ventures) has risen up the ranks to focus on life science of the future generations.
Rocklage’s approach has proved to win the scientific component over time in finding the right companies to fund as an investment opportunity. He terms his ideas for 5AM Ventures as ones that contain life-science which is made a reality by working closely with entrepreneurs who may be physicians, other scientists or business executives.
He counts on his ability to be well organized as a habit that helps him to be more productive. Further, he focuses on his strengths as well as what his business knows well as the key strategy to the enormous growth of the teams he has lead. One of the key learning he has pulled from his road to success is ‘never be afraid of taking risks.’
Learn more about Scott Rocklage: